CVS Competitors

Stocks . UK . 
Stock . CVS Health Corp
0HRS Stock   74.34  0.82  1.12%   
CVS Health Corp competes with Datadog, Cornish Metals, Extra Space, Southern Copper, and Datagroup; as well as few others. The company operates under Commercial Services & Supplies sector and is part of Industrials industry. Analyzing CVS Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of CVS Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out CVS Health Correlation with its peers.

CVS Health vs Science Applications Correlation

Modest diversification

The correlation between CVS Health Corp and 0V9N is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CVS Health Corp and 0V9N in the same portfolio, assuming nothing else is changed.
Hype
Prediction
LowEstimatedHigh
72.2074.3476.48
Details
Intrinsic
Valuation
LowRealHigh
73.8575.9878.13
Details
Naive
Forecast
LowNextHigh
70.6672.8074.94
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
74.0679.0884.10
Details

CVS Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between CVS Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of CVS and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of CVS Health Corp does not affect the price movement of the other competitor.

High positive correlations

0L8B
+ 0.94
TIN
0KS3
+ 0.86
0IJV
0V9N
+ 0.81
0W19
0V9N
+ 0.8
0L8B
0IJV
+ 0.77
TIN
0W19
+ 0.74
0L8B
  

High negative correlations

RDT
- 0.58
TIN
RDT
- 0.55
0L8B
0IJV
- 0.52
0A3O
0KS3
- 0.5
0A3O
TIN
- 0.41
0A3O
RDT
- 0.4
0IJV

Risk-Adjusted Indicators

There is a big difference between CVS Stock performing well and CVS Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CVS Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

CVS Health Competitive Analysis

The better you understand CVS Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, CVS Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across CVS Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
0HRS 0A3O TIN 0IJV 0L8B 0W19 0KS3 RDT 0V9N
 1.12 
 74.34 
CVS
 9.15 
 128.90 
Datadog
 8.43 
 135.00 
Cornish
 0.22 
 138.77 
Extra
 7.09 
 208.06 
Southern
 0.28 
 70.70 
Datagroup
 0.36 
 276.31 
Public
 11.43 
 3.10 
Rosslyn
 1.21 
 102.67 
Science
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Slightly risky
Very steady
Market Performance
(90 Days Performance)
Weakest
Weakest
Solid
Soft
Solid
Fair
Weakest
Weakest
Mild
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Small
Low
Low
Low
Low
Low
Risky
Low
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Hold
Strong Hold
Hold
Strong Buy
Sell
Hold
Sell
Hold
Net Asset
253.22 B
5.79 B
123.46 M
28.85 B
18.71 B
582.17 M
19.75 B
4.33 M
5.25 B
Profit Margin
0.0012
0.0332
N/A
0.28
0.31
0.0384
0.39
-0.84
0.0505
EBITDA
13.68 B
317.99 M
(8.83 M)
2.26 B
6.54 B
86.47 M
3.33 B
(1.83 M)
694 M
Operating Margin
0.0227
-0.0066
N/A
0.46
0.52
0.0688
0.47
-0.92
0.0686
Current Valuation
164.03 B
44.44 B
1.04 B
43.94 B
162.12 B
770.41 M
62.5 B
2.17 M
7.48 B
Price To Book
N/A
N/A
9.93
N/A
N/A
N/A
N/A
1.25
N/A
Retained Earnings
62.84 B
30.05 M
(43.46 M)
(899.34 M)
6.84 B
115.05 M
(699.08 M)
(24.55 M)
1.56 B
Beta
0.48
1.26
0.38
1.27
1.07
1.29
0.99
0.2
0.27
Number Of Employees
219 K
6.5 K
4
8.01 K
16.13 K
4.06 K
5.9 K
44
24 K
Shares Outstanding
1.02 B
N/A
1.25 B
127.45 M
773.04 M
8.33 M
174.42 M
73.99 M
42.49 M
Cash Flow From Operations
9.11 B
870.6 M
(4.46 M)
1.89 B
4.42 B
34.27 M
3.14 B
(1.37 M)
494 M
Annual Yield
2.0E-4
N/A
N/A
N/A
N/A
0.0222
N/A
N/A
N/A
Total Debt
82.92 B
1.84 B
13.46 M
13.03 B
7 B
203.57 M
9.35 B
478 K
2.39 B
Return On Equity
0.0058
0.0352
N/A
0.0679
0.39
0.14
0.2
-2.13
0.24
Return On Asset
0.025
-0.005
N/A
0.0335
0.2
0.0511
0.0702
-0.43
0.0596
Book Value Per Share
57.42
9.81
0.083
64.16
12.76
20.55
28.28
0.015
33.6
Total Asset
253.22 B
5.79 B
123.46 M
28.85 B
18.71 B
582.17 M
19.75 B
4.33 M
5.25 B
Last Dividend Paid
2.66
N/A
N/A
6.48
N/A
0.04
12.0
N/A
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
N/A
N/A
20.0
N/A
Shares Owned By Institutions
89.98
93.48
33.6
99.1
9.49
6.0
82.03
54.68
86.91
Market Capitalization
69.19 B
N/A
1.03 B
1.85 T
109.1 B
594.74 M
4.85 T
2.29 M
693.55 B
Price To Sales
0.25
N/A
N/A
5.42
15.38
1.04
10.12
0.76
0.94
Net Income
4.59 B
183.75 M
(1.07 M)
900.23 M
3.39 B
21.95 M
2.07 B
(2.52 M)
362 M
Earnings Per Share
6.01
0.003
-0.01
6.18
4.42
2.72
10.29
N/A
4.68
Shares Owned By Insiders
1.06
0.7
34.43
0.98
89.74
63.5
10.18
28.33
0.65
Revenue
372.81 B
2.68 B
N/A
3.34 B
11.43 B
566.08 M
4.7 B
3 M
7.48 B
Working Capital
N/A
N/A
(1.35 M)
N/A
N/A
N/A
N/A
(68 K)
N/A
Gross Profit
52.3 B
2.57 B
N/A
2.56 B
7.35 B
112.45 M
3.49 B
1.22 M
883 M
Day Typical Price
74.31
131.75
131.0
137.99
208.5
70.7
276.18
3.1
103.77
Accumulation Distribution
46.59
897.87
41560.0
0.0339
1191.23
N/A
0.12
1993.31
1.94
Market Facilitation Index
4.0E-4
9.0E-4
0.0
1.18
0.0016
N/A
0.66
0.0
0.0592
Daily Balance Of Power
0.7009
(1.23)
0.875
(0.13)
0.682
9.2 T
0.216
(2.00)
(0.36)
Period Momentum Indicator
0.82
(12.99)
10.5
(0.30)
13.77
0.2
1.0
(0.40)
(1.26)
Rate Of Daily Change
1.01
0.91
1.08
1.0
1.07
1.0
1.0
0.89
0.99
Day Median Price
74.29
133.18
129.0
137.6
208.72
70.7
276.12
3.1
104.32
Price Action Indicator
0.46
(10.77)
11.25
1.03
6.23
0.1
0.69
(0.20)
(2.28)
Relative Strength Index
42.6
N/A
77.58
53.55
77.5
58.99
50.94
30.95
49.57
Coefficient Of Variation
(1,857)
(665.05)
345.31
(2,038)
342.73
770.58
(1,473)
(2,005)
1405.78
Mean Deviation
1.3
2.03
2.09
1.25
1.99
0.8314
1.13
0.3866
1.44
Jensen Alpha
(0.16)
(0.52)
0.8376
(0.11)
0.6807
0.1526
(0.14)
(0.09)
0.1574
Total Risk Alpha
(0.28)
(0.67)
0.6218
(0.21)
0.5494
0.0621
(0.21)
(0.21)
(0.01)
Sortino Ratio
N/A
N/A
0.3545
N/A
0.3229
0.0862
N/A
N/A
0.0655
Downside Variance
N/A
N/A
4.77
N/A
4.39
1.26
N/A
N/A
3.5
Standard Deviation
2.18
2.98
2.89
1.66
2.53
1.22
1.46
1.62
2.58
Kurtosis
19.37
3.02
2.32
2.81
(0.03)
4.28
0.2929
40.55
19.04
Potential Upside
2.43
4.32
6.41
2.59
4.81
1.85
2.37
N/A
2.76
Treynor Ratio
(0.19)
(0.41)
(3.60)
(0.32)
0.786
(1.74)
(0.20)
1.26
0.5418
Maximum Drawdown
16.48
11.33
16.33
6.56
8.98
8.47
7.24
17.49
22.54
Variance
4.77
8.88
8.33
2.77
6.4
1.49
2.13
2.64
6.68
Market Risk Adjusted Performance
(0.18)
(0.40)
(3.59)
(0.31)
0.796
(1.73)
(0.19)
1.27
0.5518
Risk Adjusted Performance
(0.03)
(0.10)
0.2177
(0.03)
0.219
0.0983
(0.04)
(0.03)
0.0588
Skewness
(3.44)
0.2209
1.2
(0.35)
0.2873
0.7193
0.5352
(4.55)
2.94
Semi Deviation
N/A
N/A
1.1
N/A
1.53
0.8716
N/A
N/A
1.66
Information Ratio
(0.08)
(0.17)
0.2684
(0.09)
0.2675
0.0795
(0.11)
(0.09)
0.0474
Value At Risk
(2.17)
(3.60)
(1.96)
(2.11)
(3.56)
(1.99)
(2.21)
N/A
(2.43)
Expected Short fall
N/A
N/A
(3.43)
N/A
(2.46)
(1.03)
N/A
N/A
(1.82)
Downside Deviation
N/A
N/A
2.18
N/A
2.1
1.12
N/A
N/A
1.87
Semi Variance
N/A
N/A
1.21
N/A
2.35
0.7597
N/A
N/A
2.76

CVS Health Competition Performance Charts

Five steps to successful analysis of CVS Health Competition

CVS Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by CVS Health Corp in relation to its competition. CVS Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of CVS Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact CVS Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to CVS Health Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your CVS Health position

In addition to having CVS Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Moderate Funds Thematic Idea Now

Moderate Funds
Moderate Funds Theme
Funds or Etfs that combine stocks, bonds and money market instruments to get modest capital appreciation over time. The Moderate Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Moderate Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for CVS Stock Analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY